Logos Global Management’s Achieve Life Sciences QUIT Stock Holding History

Logos Global Management’s Portfolio QUIT Stock Details QUIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$35.4M	Buy	+5,425,000	New	+$25.9M	1.53%	20

Other funds holding QUIT

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Logos Global Management's QUIT Position: Q2 2026 in Review

Logos Global Management opened a new position in Achieve Life Sciences (QUIT) in Q2 2026: 5,425,000 shares worth $35.4M. The stake represents 1.53% of the portfolio and ranks #20 among its holdings.

112 funds tracked by Wall St. Rank hold QUIT as of Q2 2026.

Logos Global Management held 5,425,000 shares of Achieve Life Sciences worth $35.4M as of Q2 2026.
Achieve Life Sciences was a new Logos Global Management position in Q2 2026.
Achieve Life Sciences made up 1.53% of Logos Global Management's portfolio in Q2 2026, its #20 holding.
112 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on Logos Global Management's 13F filing for Q2 2026, filed 14 Aug 2026.